Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
STI Pharma is a pharmaceutical company focused on the development, manufacturing, and marketing of generic prescription drugs. The company is notably recognized as a manufacturer of Triacin-C, a combination syrup containing triprolidine, pseudoephedrine, and codeine used for the symptomatic relief of cough and upper respiratory symptoms. STI Pharma manages a portfolio of essential generic medications, ensuring access to affordable treatments for common conditions such as allergies and respiratory illnesses. The company operates within the United States, adhering to stringent regulatory standards for the production of controlled substances and general pharmaceuticals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Makers of Triacin.